BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23884018)

  • 1. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
    Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
    MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
    Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
    Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.
    Esquerda-Canals G; Marti J; Rivera-Hernández G; Giménez-Llort L; Villegas S
    MAbs; 2013; 5(5):660-4. PubMed ID: 23884149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
    PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
    Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
    Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.
    Roda AR; Montoliu-Gaya L; Serra-Mir G; Villegas S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy.
    Güell-Bosch J; Lope-Piedrafita S; Esquerda-Canals G; Montoliu-Gaya L; Villegas S
    NMR Biomed; 2020 May; 33(5):e4263. PubMed ID: 32067292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden.
    Esquerda-Canals G; Roda AR; Martí-Clúa J; Montoliu-Gaya L; Rivera-Hernández G; Villegas S
    J Alzheimers Dis; 2019; 70(4):1069-1091. PubMed ID: 31306135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.
    McKee AC; Carreras I; Hossain L; Ryu H; Klein WL; Oddo S; LaFerla FM; Jenkins BG; Kowall NW; Dedeoglu A
    Brain Res; 2008 May; 1207():225-36. PubMed ID: 18374906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic parameters and mechanism of action of an efficient anti-Aβ single chain antibody fragment.
    Esquerda-Canals G; Martí-Clúa J; Villegas S
    PLoS One; 2019; 14(5):e0217793. PubMed ID: 31150495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
    Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles.
    Li JG; Chu J; Barrero C; Merali S; Praticò D
    Ann Neurol; 2014 Jun; 75(6):851-63. PubMed ID: 24644038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.